NWBO
Northwest Biotherapeutics Inc
Mentions (24Hr)
500.00% Today
Reddit Posts
The Market Maker's Kryptonite: Civil Spoofing Exposure
The American System - Profits Over Life; A Tiny Biotech's Battle to Bring a Cancer Vaccine to Market
$NWBO Awaits MAA Approval: I love biotech
From Pennies to Benjamins: Multiply your $1 with these penny stocks!
$MGUY - Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)
$NWBO could see some great upside in the near future
$NWBO lawsuit against market makers and upcoming MHRA application
Groundbreaking Phase II Trial on Gliomas Unveils a Promising Future for $NWBO DCVax Combinations
The American System - Profits Over Life; $NWBO’s Battle to Bring a Cancer Vaccine to Market
Brain Cancers Forum and Aivita abstract relative to $NWBO DCVax
Will the current short attacks bankrupt NWBO or is it a buy?
$NWBO A look at Dr. Bosch's Glioblastoma Summit presentation last week
NWBO potential massive rip in very near future
$NWBO Short Position & no Regulation SHO Threshold Flags!
Quick takeaway messages from the $NWBO 10-Q
New JAMA review discussing glioblastoma and my comments relating to $NWBO DCVax-L
NWBO Stock: Citadel Chooses to Profit from Cancer Drug Company
$NWBO’s Studies that cannot be named…yet…with incredible implications for partnerships/buyout
The challenge of attacking glioblastoma and $NWBO’s victory with DCVax-L
NWBO SUING Fuck Face Ken Citadel and his friends for Market Manipulation.
$NWBO SUING Fuck Face Ken Citadel and his friends for Market Manipulation.
This one is all over the net. NWBO more info. Video
The challenge of attacking glioblastoma and $NWBO’s victory with DCVax-L
NWBO: Filed lawsuit against the entities that participated in SPOOFing against us this gonna be HUGE!!!
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit
NWBO suing Wall Street firms over market manipulation
Epic short squeeze could make $NWBO the next $GME
Another SHITadel lawsuit, this time for illegally shorting a biotech company (NWBO) that’s curing cancer
Anyone following the NWBO situation?
$NWBO ready to soar after announcing biggest cancer breakthrough in 30 years
NWBO huge volume and rally this week. iHub and Twitter are claiming huge short positions. Possible short squeeze opportunity?
Time To Load $NWBO - The First Real Cure For Cancer
4 Penny Stocks to Buy: NWBO ENZC SYSX MULN
$NWBO - review of yesterdays events and thoughts on the future of this stock
How did your accounts do today in this bloody market? $NWBO
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Bull Run as Biotech Set to Release Phase III Top Line Data for DCVax®-L May 10 / Dr. Linda Liau Will Present “Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Glioblastoma” at the New York Academy of Sciences
$NWBO thoughts on Timing, Addressable Market, Trial Results
$NWBO Leading Brain Cancer Vaccine Attacked By Shorts
Mentions
People having been saying that for NWBO for years now. I hold a small amount, but I have little faith at this point.
Please be aware I do have a potential conflict of interest here because I own over 1,000 shares of NWBO. You need to know how to read research papers, how to verify sources, and most importantly any tiny thing that you can use to tear them apart. While also being able to think like an investor. The burden of proof is on those who publish and not the reader. All it takes is a 👍 or 👎 from a group of regulator’s. One you make an assload of a gains the other near certain catastrophic loss in the stock you have. These are not MRK, GSK, J&J, and LLY that can /will soak up billion dollar losses on a drug and still have 40 others in the pipeline Will maintaining profitability. Small biotechs are very vulnerable to data manipulation, fraud, and regulatory scrutiny. I mean you need approval for profit. (Or a buyout) You have Assholes who will defraud people at all costs. Then the FDA is notorious for picking on the little guy. They don’t have the big legal teams. Only invest in if you trust the data and the conclusions that other professionals completely unrelated to the study have come to. Per google there are issues with NWBO’s study. “the company made fundamental changes to the trial design, used questionable statistical methods, and demonstrated a profound lack of transparency” The changes and statistical methodology is fine if it can be verified and replicated in other trials. The lack of transparency is a huge problem with the company. It is the big thing that makes me nervous. Anyway just my thoughts on NWBOz
Hey, totally get your point fair to be cautious with any biotech, especially one that’s been around this long. But here’s the thing the Advent BioServices deal wasn’t just some internal shuffle. It was a regulatory and manufacturing move that MHRA actually requires before commercialization. You can’t sell a personalized cell therapy without your own licensed manufacturing setup, and now NWBO owns that 100%. They’ve been in active review with the MHRA (confirmed by NICE in April 2025), and closing Advent right now basically signals they’re preparing for the revenue stage, not just staying in the research phase. Yes, the wait’s been long but that’s typical for advanced therapies under UK/EMA review. The fundamentals are aligning: infrastructure done, regulatory path clear, and float still cheap. To me, that’s not hopium that’s asymmetric setup.
When I dig into this stock, I see more red flags than green. It's possible for this to go up on Monday, but I require significantly more convincing. - SEC filings about a massive public offering... surprisingly a nothingburger because it's just a renewal of previous registrations; already priced in until the offering is ever actually closed. Still, *another billion* shares to the float looming over your head is pretty fuckin' scary. I look at this and I look at their stock price history and that's all I really need to know to raise alarms. They're serially dilutive and will continue to rely on dilution to stay afloat. Nothing unusual for a penny stock here. That doesn't mean that there isn't a play to be made here, but if there is, be under no illusions that the stock price will last. They have pre-emptively prepared to basically double the share count. You do not want to be left holding this stock. - Their acquisition of Advent is actually a reacquisition of Cognate Bio, which indeed was their manufacturing arm but used to be owned by NWBO execs and they had to sell it off because they were overcharging by 50x compared to peers? I did not dig in to verify this information, but again, red flag. What's the actual play here, OP? Their phase 3 trial results were positive, cool. They're waiting on marketing approval and they have been doing so for almost two years, it seems? And mind you, passing phase 3 trials is impressive, but it is no guarantee of marketing approval. In fact it's little better than a coin flip. Without the timeline estimate, I wouldn't even be able to do my usual biotech play of waiting for the run-up to the trial results and then jumping ship right before the announcement. Waiting for a binary event at an unknown date doesn't sound like an opportunity to me, OP. It sounds like hopium.
Great breakdown! NWBO looks like it’s finally lining things up for a real breakout. The acquisition and MHRA timeline make a lot of sense — thanks for putting this together 🙌
Holy tamale...1.5 BILLION shares outstanding! Good chance company will get approved in UK for it lead product before end of year, but on the other its application for approval in the UK has been sitting with the MHRA (UK version of the FDA) since Dec. 21, 2023. MHRA is going very slow on this. NWBO could see a decent pump after UK approval. Long term tough to see how they avoid future dilution (as if 1.5 billion shares outstanding were not insane enough) given their near none-existent cash position (was $2.2 million in the spring; not sure exactly what it is now). Shelf registration for $250 million not a positive - it is a clear message that future additional dilution is certain. IMO a good plan would to take a position in preparation for the UK approval, sell pump from UK approval, if still interested in the stock then buy back after the price drop that will occur from the inevitable future dilution and/or reverse split.
PSTV, NWBO, RITE and NXGB are my current hella low cost longs.
Buy NWBO now!!! As I stated two days ago, it’s been quiet for good reason and it’s just closed it’s acquisition. The ball starts rolling now.
NWBO (Northwest Biotherapeutics Inc.)
Opinion on NWBO - MHRA approval any day
Penny stocks in biotech in the verge of causing a paradigm shift in Oncology therapy: Cydy and NWBO .
$NWBO, because I believe that DCVax can cure some really horrible cancers.
NWBO still a highly undervalued stock. Not a get rich quick scheme, likely need to see news of the acquisition finalizing and then implementation. I’m holding for the foreseeable future and suggest people do the same after some DD.
NWBO’s DCVax-L cancer vaccine is awaiting MHRA approval. That should happen any day now and it’s currently trading at $0.25 ps
ELPW has had some time to allow their new leadership to settle in, they’ve been prime to bounce back since they tanked in June and July due to resignations. NWBO has an acquisition that will change their business model and allow for a more well rounded company.
Progress at NWBO is still very real, even if it isn’t obvious to the market. Over the past year, there has been steady steps forward in manufacturing readiness, regulatory interactions, and positioning for partnerships that point toward eventual commercialization of DCVax-L. Importantly, the science hasn’t stood still, clinical data remain highly compelling, and the broader environment for cell based immunotherapies has only strengthened. That’s why my conviction in the successful commercialization of DCVax-L is actually stronger today than it was last year. The long path has been frustrating, but the foundation being laid now is what makes real, lasting success possible. That said, investing here requires patience, conviction, and a tolerance for risk. If you have a low appetite for risk or limited capital, you’re better off just buying treasuries or putting your money in a CD.
What is everyone thinking about NWBO, is it worth investing in? Some say that it is close to approval.
ATYR, ACHV, CLRB, -- gamble NWBO
PSTV, AERT, and NWBO are promising.
LP owned 75% of Toucan, which owned Advent. This deal is very positive for $NWBO — she essentially sold it for pennies. Advent is finally back where it belongs: with us, the investors. We’ll also get more transparency now, seeing the actual GMP revenue and any transactions made by Advent.
Saw an old press release that Linda Powers was the Director of Advent. If correct, then this isn't as clean a transaction as it looks, nor is it as indicative of a boost for NWBO. It's more likely a way to pull coin out of nwbo while the rest of us hold the bag. Pump 'n dump.
NWBO pummmmmpin right now no idea for how long though
I decided to take a chance on NWBO. After reading what they are doing and how close they are to approval in GB and then likely in the USA, I had to jump in. Yes, HR/HR
$NWBO *should* be doing better than it is at the moment, but isn't because of the main pharma companies. I have I think 1350 shares, bought in 3 different times, as the price was going down.
NWBO. Been watching it for a while. Not sure if I’m just listening to pumpers, but I’m convinced an MHRA decision is coming very soon. Keep an eye out for this one.
NWBO. Been watching it for a while. MHRA decision is coming very soon. Keep an eye out. Lots of people have been waiting a VERY long time for this.
Gonna start loading up on $NWBO. People have been pumping that for years. But looking at all the catalysts with recent MHRA updates and their MAA, a fork in the road is coming extremely soon. I think they’re either getting a big denial for DCVax-L or an approval. My bets on approval- we’ll see.
Why NWBO Could Be the Next Big Blockbuster: 1️⃣ Revolutionary Platform — DCVax® NWBO’s DCVax®-L is a personalized dendritic cell vaccine for brain cancer (specifically glioblastoma), which also shows potential applicability to 90% of solid tumor cancers. If validated and approved broadly, this moves NWBO from a niche brain cancer player to a universal solid tumor immunotherapy company — a $100B+ market space. ⸻ 2️⃣ Phase 3 Trial Results Were Groundbreaking In 2022, NWBO’s long-awaited Phase 3 glioblastoma trial results showed: • Median survival for newly diagnosed GBM patients increased to 23.1 months with DCVax-L versus 15–17 months typically. • Long tail of survival: a significant subset of patients lived beyond 5 years, extremely rare in GBM. That kind of survival curve flattening is a hallmark of effective immunotherapy (think: Keytruda’s early melanoma data). And the Phase 3 trial was blinded, randomized, and international — the gold standard. ⸻ 3️⃣ MHRA Approval Decision Imminent NWBO filed for regulatory approval with the UK’s MHRA for DCVax-L. Industry watchers believe approval could come in 2024–2025, and if granted, it would be the first approved personalized cancer vaccine for brain tumors in the world. This would also set the stage for: • Fast-tracked approvals in Europe and potentially under FDA’s Breakthrough or Accelerated Pathway. • Expanded trials/approvals for other solid tumors like ovarian, colon, pancreatic, and lung. ⸻ 4️⃣ Undervalued & Heavily Shorted At ~$0.22/share, NWBO’s market cap sits around $270M — a fraction of what comparable companies fetched at similar development stages: • Kite Pharma was bought by Gilead for $11.9B at Phase 2/early Phase 3 CAR-T stage. • ImmunoGen (antibody-drug conjugates) just sold for $10.1B. NWBO has been a target of documented short and distort campaigns for over a decade, potentially suppressing its value. When (not if) a major regulatory milestone arrives, the short squeeze and revaluation could be violent and swift. ⸻ 5️⃣ Broader Pipeline & CMO Control Beyond DCVax-L, NWBO owns: • DCVax-Direct — for inoperable solid tumors (Pancreatic, Sarcoma, etc.) • Full control of Advent Bioservices — their own GMP-certified manufacturing facility in London, which enables them to rapidly scale and control margins (rare for small biotechs). ⸻ ✅ Bottom Line: If MHRA approval lands and/or new partnerships emerge, NWBO could go from obscure microcap to biotech blockbuster virtually overnight. A platform immunotherapy for solid tumors would be generationally valuable — and NWBO may have it.
Hey, I bought GALT on Friday based on the information you provided. Don’t worry you’re just a source of information you never claimed to be financial advice. Bio tech stocks are notoriously manipulated by market makers and people who would benefit from poor health care. It’s sick and evil but it’s what we have to deal with. Im in the same position with NWBO. I bought GALT at 2.5, when eventually the data is so obvious there’s no way to lie, the product will be fine and short sellers will have no chance
Anyone playing with NWBO?
I have one that i've been sitting on for more than a year. NWBO. id like to post my chatgpt link on this because if it provides a nice overview of the company's current situation [Chatgpt: NWBO stock evaluation](https://chatgpt.com/share/e/68278c95-cb54-8007-8149-0847c8d7503c) The last thing I'll say about this is that, it has dropped over the year, it's waiting on UK MHRA approval as its phase 3 trials were already successful, the current valuation is a little higher than the 52 week low, and its pursuing the largest spoofing case against some of the largest hedge funds including Citadel, Virtu, Cannacord, etc. They survived a motion to dismiss. The case is now entering the discovery phase This is for informational purposes only. I am not a financial advisor.
Anyone buying $NWBO. Phase three pass DCVax-L for Glioblastoma. Could be huge
I would go with NWBO. They finished the phase 3 and should get their approbation for a cancer vaccine any day now. Will probably go from 0,28$ to 20$ and more.
NWBO. In a few days they’ll get MHRA approval for the first cancer vaccine. Phase 3 completed and peer reviewed. Fully derisked. Should go from 0.28 to 20$ and more any day now.
NWBO and KULR are my hot picks
Sounds like a NWBO 2.0 which would have been a great investment /s
Google will answer one of those better than I can, and holding $NWBO and $LIPO, watching $BCTX
They seem like they’re working on similar products, but tbh I’m regarded and haven’t looked too much into them. Do you have a price target for NWBO? 12mo or 5y target?
How does NWBO compare to IOVA?
Also long on $NWBO and as much as I hope the price moons, i really think they have a chance to cure some super shitty cancers.
I was like, NWBO... that sounds familiar... Sure enough, there is a NWBO position collecting dust at the bottom of my port, where all the sediment of poorly researched impulsive decisions accumulates eventually. Bought 1k shares at 0.56 a while ago for no reason I can recall, it closed at 0.29 last Friday. Weeks away from 100x, huh? Neat-o.
$NWBO. Lead vaccine candidate dcvax is weeks away from approval in UK. As production ramps and more approvals are realized, this will be a 100x. Dendritic cell therapy is the future of cancer treatment and NWBO will be the leader
$NWBO, the most hated on biotech penny stock of all time.
NWBO - Will be franchising/licensing their patents along with their flaskworks device for dendritic cell/immunotherapy production
Notice NWBO isn’t on this list #junkstock
Should have bought NWBO when it was at $0.31 before MHRA approval in October 2024. Oh well, biotech sucks anyway
NWBO does about 2 to 3 million on average I believe. I'm not really sure waht this is likely to get other than one thing that I care about - it's likely to get bought out. I don't care about the day trading, I don't care about the FUDs, I don't care about the shorts. None of them matters any more. It's game over. GG. This is getting bought out. Merry Christmas.
NWBO. Successful Stage 3 clinical trial improves cancer outcomes and when paired with other drugs leads to stunning recovery across multiple types of cancers.
Starting to lose hope- but NWBO
100% on Northwest Biotherapeutics (NWBO). Cancer breakthrough therapy on the cusp of approval by British MHRA with 10´s of $billions of forecasted revenues after 20 years of research ! Keep shares forever…
NWBO is a very shitty otc biotech stock that I like a lot
I hope they do. I'm an advocate for the advancement of better medical treatments for healthy life longevity. I will keep an eye on this one. You should also check out NWBO? They have already started human trials with success for glioblastoma. They've also already submitted an application for approved use in the UK. For now, special cases are allowed to use the treatment
$NWBO. A moonshot cancer drug that is suing Citadel and others for market manipulation.
You should have $ELTP in your list. If you are doing research, it might help to have a company that actually is cash flow positive. It’s not flashy. It’s not creating lithium out of beaver urine. It isn’t creating nano dyospheres surrounding nano hydrogen fusion spheres. It is a simple, small, generic drug company that is run by a solid CEO who navigated them not getting approval on an exciting anti abuse technology through tough waters until they could get enough drugs approved to start selling. While their sales partner went from a 3.2 billion valuation to bankruptcy. $ELTP has consistently increased revenue quarter after quarter. If I had to guess at another one to study. It might be $NWBO. The people who support the cancer treatments and team are zealous. The naysayers say this is an absolute scam. I personally haven’t investigated $NWBO to have an opinion one way or the other, but this one may be interesting since it fell from grace and got delisted. Full disclosure- I own millions of shares in $ELTP and zero shares of $NWBO. Those are the only two I can think of for your research as I don’t usually invest in penny stocks.
I think they are trying to hide NWBO by showing you FFIE. But this isn't financial advice anyway lololol 😅 🙃 😂 🤣 😆 🤪 😅
Just fight back like NWBO : get the best lawyer and take them to court !
NWBO price was $1,000/share (adjusted for reverse splits) in 2002. Jesus rose from the dead, and if you believe in the Easter Bunny, then you can also believe that NWBO will reach $40-$60/a share.
NWBO should get dcvax approval by August Probably won’t get you the whole way back though but probably a 6x
''Every author has a bias. Might want to research the authorship bias on that article. (Hint it involves a former competitor.)'' # Which? I could cite at least another two papers, three comments left on the JAMA Oncology paper, as well as a numerous expert opinions, including one by Prof. Roger Stupp, who was a paid consultant for NWBO. All negative. ''Recent Nature article shows quite clearly that the technology does work.'' It was a small PhII that wasn't powered for survival. The combo arm only had five GBM patients. The data showed that the 5-year OS was zero. Not that impressive. ''Merck has entered into second combo trial with DC VAX. Not something you would expect with a failed product.'' Merck licensed Moderna's neoantigen vaccine in 2022 for $250 million up front [Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer Vaccine - Merck.com](https://www.merck.com/news/merck-and-moderna-announce-exercise-of-option-by-merck-for-joint-development-and-commercialization-of-investigational-personalized-cancer-vaccine/) Now three pivotal trials are ongoing. There are also three PhII trials and three PhI trials ongoing as well.
A penny stock scam. Phase Five Research published a (short) report in '15 showing (using NWBO's own filings) that since 2004 the company transferred over $300 million to Powers and private companies controlled by her, through transfer of cash, shares, warrants and options. Since then, a lot more. We also know that Powers (the CEO, President, COB (of a captured board), CFO and CAO) owns Advent (thru her Toucan investment fund) and has been funding it since inception and growing the company courtesy of NWBO bag holders. She did the same with Cognate Bioservices, which was acquired for $875M in cash. Did that money get split between her and bag holders? Of course not! What's the value of Advent? I think we'll find out soon enough.
A penny stock scam. Phase Five Research published a (short) report in '15 showing (using NWBO's own filings) that since 2004 the company transferred over $300 million to Powers and private companies controlled by her, through transfer of cash, shares, warrants and options. Since then, a lot more. We also know that Powers (the CEO, President, COB (of a captured board), CFO and CAO) owns Advent (thru her Toucan investment fund) and has been funding it since inception and growing the company courtesy of NWBO bag holders. She did the same with Cognate Bioservices, which was acquired for $875M in cash. Did that money get split between her and bag holders? Of course not! What's the value of Advent? I think we'll find out soon enough.
In the Phase 3 trial, DCVax-L demonstrated the following for newly diagnosed GBM patients: * Median Overall Survival (mOS): 19.3 months (DCVax-L group) vs. 16.5 months (control group) * Survival at 48 months: 15.7% (DCVax-L group) vs. 9.9% (control group) * Survival at 60 months: 13.0% (DCVax-L group) vs. 5.7% (control group) These results indicate a significant improvement in survival for newly diagnosed GBM patients treated with DCVax-L compared to standard treatment alone. I don't know much about insurance companies' willingness to pay, but this doesn't look like a cure so much as a life extension drug.... Are the numbers posted above enough to make DCVax-L a big earner for $NWBO? Or will be convincing insurance companies to take on the drug be an uphill battle? Enough to fire up a squeeze? Thanks for any insight.
Be following NWBO for years and I have been waiting to jump in.
Phase Five Research published a (short) report in '15 showing (using NWBO's own filings) that since 2004 the company transferred over $300 million to Powers and private companies controlled by her, through transfer of cash, shares, warrants and options. Since then, a lot more. We also know what Powers (the CEO, President, COB (of a captured board), CFO and CAO) owns Advent (thru her Toucan investment fund) and has been funding it since inception and growing the company courtesy of NWBO bag holders. She did the same with Cognate Bioservices, which was acquired for $875M in cash. Did that money get split between her and bag holders? Of course not! What's the value of Advent? I think we'll find out soon enough. The trial was a failure as well [https://www.sciencedirect.com/science/article/pii/S0035378723009190](https://www.sciencedirect.com/science/article/pii/S0035378723009190) [https://academic.oup.com/neuro-oncology/article/25/4/631/6958519](https://academic.oup.com/neuro-oncology/article/25/4/631/6958519)
A lot of purple saying Novo, MS, Nvidia etc but that's pretty off-topic as there's really not a huge risk any of them dying the next 5 years. I'm gonna say NWBO Have more invested than I like, the way it's been going so far, but a lot less than I would have liked if (WHEN!) the approval comes.
I'll beat you soon, in a few more weeks or months. I'm loaded on $NWBO and MHRA approval coming soon maybe April/May 2024. It is a biotech play of a Lifetime. Big pharma partnership or buyout can happen any time. All in my opinion :)
I hope you guys don't mind this one is of topic also pennystock. (NWBO) Northwest Biotherapeutics Inc . Very very successful trials on there DCVax-L cancer treatment. Alot of talks of Big buyout for the rights to that treatment that could talk this one from .58 to $48 if this is to happen. Thoughts
$NWBO Up pre market.......... Z
You have learned from your mistakes ( hopefully). You can and will come back. learn about NorthWest Bio ( OTC : NWBO ) with a near term potential of turning $0,56 into $100 within 36-48 months then even more. No need to invest a lot. This is not an investment advice, do your DD.